SGRY expanded its surgical facility footprint from 161 to 176 locations while achieving solid revenue growth and substantially improved net loss performance.
The company's operational expansion strategy appears to be gaining traction, with 15 new facilities added during the year and revenue growing 19.3% to $1.1 billion. The meaningful improvement in net losses, combined with higher operating income, suggests the business is achieving better operational leverage as it scales.
SGRY delivered solid financial performance with revenue growing 19.3% to $1.1 billion and operating income advancing 11.7% to $389.5 million. Most notably, net losses improved substantially from -$168.1 million to -$77.9 million, indicating meaningful progress toward profitability. Cash declined modestly to $239.9 million, reflecting typical working capital needs as the business expands.
Net income grew 53.7% — bottom-line growth signals improving overall business health.
Revenue growing 19.3% — solid top-line momentum, watch margins for quality of growth.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
Cash decreased 11% — monitor burn rate and upcoming capital needs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →